Clinical trial

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

NCT06672549

View saved research
StatusRECRUITING
Study typeINTERVENTIONAL
Start date2024-11-18
PhasePHASE3

Study timeline

Study start (actual)2024-11-18Date precision: day
Registry last updated2026-10-07
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

What this registered study describes

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) is a interventional study listed under registry identifier NCT06672549. Its last published status is RECRUITING. Registry status does not establish that enrollment is currently open at every study site.

The published record lists 2 condition label(s), 2 intervention label(s), and 1 sponsor/collaborator entry or entries. The structured information below allows these links to be examined individually; intervention registration is not an efficacy claim.

Source: the original ClinicalTrials.gov study record. Always check the protocol, eligibility, dates, results (when posted), and contacts at the original source.

Mapped research locations

HoustonTexas, United States4SeoulSouth Korea3WarsawPoland3ChicagoIllinois, United States2Los AngelesCalifornia, United States2OrlandoFlorida, United States2OmahaNebraska, United States2CharlestonSouth Carolina, United States2BrusselsBelgium2RomaItaly2JerusalemIsrael2WroclawPoland2PortoPortugal2BostonMassachusetts, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1NashvilleTennessee, United States1MadridSpain1BarcelonaSpain1SeattleWashington, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1DurhamNorth Carolina, United States1IndianapolisIndiana, United States1MinneapolisMinnesota, United States1Oklahoma CityOklahoma, United States1AustinTexas, United States1New HavenConnecticut, United States1RochesterMinnesota, United States1RichmondVirginia, United States1TucsonArizona, United States1Chapel HillNorth Carolina, United States1SevilleSpain1LouisvilleKentucky, United States1BuffaloNew York, United States1LeuvenBelgium1OrangeCalifornia, United States1KrakowPoland1São PauloBrazil1MálagaSpain1LodzPoland1TacomaWashington, United States1HaifaIsrael1Colorado SpringsColorado, United States1OsakaJapan1Grand RapidsMichigan, United States1LisbonPortugal1St. PetersburgFlorida, United States1Petah TikvaIsrael1Mexico CityMexico1Ramat GanIsrael1Saint PaulMinnesota, United States1CambridgeUnited Kingdom1FlorenceItaly1LiverpoolUnited Kingdom1KyotoJapan1BristolUnited Kingdom1Loma LindaCalifornia, United States1GuadalajaraMexico1

Clinical trial site map

Published registry research cities for this specific study. Pins represent city-level locations, not exact facility addresses. Confirm current enrollment and facility details with the study team.

61 published city locations shown (maximum 300). Some registry locations may not have coordinates or may not be published yet.

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.